Agios Pharma (AGIO) Tops Q3 EPS by $1

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of $16.22, $1.00 better than the analyst estimate of $15.22. Revenue for the quarter came in at $9 million versus the consensus estimate of $9.47 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Paramount Skydance, Warner Bros spiking higher on volume
• Varonis Systems (VRNS)1500 contracts of June 70 calls trade, share price up 11.5%